Categories
FDC Limited — Updates, 18-05-2026: General Updates
18-05-2026 · 10:44 am
FDC secured USFDA ANDA approval for Cefixime for Oral Suspension (100 mg/5 mL & 200 mg/5 mL). This business development expands its product offerings in the US market, potentially boosting future sales.
No comments yet. Be the first to comment!